Insider trading

Period: 120 months Stock: CDXS Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

28 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

28 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

28 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

28 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
28 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
28 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

28 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
24 Feb 2026
Lutz Stefan Chief Scientific Officer
Sold at will
$6.64K 5,862 at 1.13
4.3%
Not planned
6 Feb 2026
Erbez Georgia See Remarks
Sold at will
$5.00K 3,826 at 1.31
5.4%
Not planned
6 Feb 2026
Lutz Stefan Chief Scientific Officer
Sold at will
$3.26K 2,492 at 1.31
1.8%
Not planned
7 Jan 2026
Sold at will
$7.95K 4,685 at 1.70
3.3%
Not planned
13 Oct 2025
MOORE ALISON Chief Technical Officer
Sold at will
$15.63K 6,239 at 2.51
3.6%
Not planned
11 Sep 2023
Norrett Kevin Chief Operating Officer
Bought
$15.48K 9,000 at 1.72
10.1%
First buy on file
8 Sep 2023
DILLY STEPHEN GEORGE See Remarks
Bought
$100.95K 58,479 at 1.73
15.4%
First buy on file
8 Sep 2023
Bought
$20.06K 11,834 at 1.70
17.0%
First buy on file
8 Mar 2023
DILLY STEPHEN GEORGE See Remarks
Sold, plan not stated
$122.93K 26,987 at 4.56
6.6%
8 Mar 2023
Norrett Kevin Chief Operating Officer
Sold, plan not stated
$37.62K 8,258 at 4.56
8.5%
8 Mar 2023
Sold, plan not stated
$35.01K 7,686 at 4.56
9.9%
7 Mar 2023
DILLY STEPHEN GEORGE See Remarks
Sold, plan not stated
$129.28K 28,088 at 4.60
6.5%
7 Mar 2023
Norrett Kevin Chief Operating Officer
Sold, plan not stated
$39.56K 8,596 at 4.60
8.1%
7 Mar 2023
Sold, plan not stated
$36.82K 8,000 at 4.60
9.4%
14 May 2019
Lalonde James SVP, R&D
Sold, plan not stated
$45.06K 2,378 at 18.95
1.8%
13 May 2019
Lalonde James SVP, R&D
Sold, plan not stated
$327.96K 17,621 at 18.61
11.7%
12 Feb 2019
Lalonde James SVP, R&D
Sold, plan not stated
$194.30K 8,957 at 21.69
6.3%
11 Feb 2019
Lalonde James SVP, R&D
Sold, plan not stated
$193.26K 8,958 at 21.57
5.9%
13 Nov 2018
Lalonde James SVP, R&D
Sold, plan not stated
$102.40K 6,726 at 15.22
4.3%
12 Nov 2018
Lalonde James SVP, R&D
Sold, plan not stated
$104.72K 6,727 at 15.57
4.1%
5 Sep 2018
Lalonde James SVP, R&D
Sold, plan not stated
$214.85K 12,381 at 17.35
7.0%
4 Sep 2018
Lalonde James SVP, R&D
Sold, plan not stated
$307.35K 17,915 at 17.16
9.2%
17 Jul 2018
Lalonde James SVP, R&D
Sold, plan not stated
$114.55K 7,500 at 15.27
3.7%
16 Jul 2018
Lalonde James SVP, R&D
Sold, plan not stated
$116.46K 7,500 at 15.53
3.6%
17 May 2018
Aldridge Michael D. See Remarks
Sold, plan not stated
$297.86K 22,000 at 13.54
100%
Sold half or more
15 May 2018
Aldridge Michael D. See Remarks
Sold, plan not stated
$283.95K 22,000 at 12.91
100%
Sold half or more
15 May 2018
Lalonde James SVP, R&D
Sold, plan not stated
$129.03K 10,000 at 12.90
4.5%
14 May 2018
Lalonde James SVP, R&D
Sold, plan not stated
$130.90K 10,000 at 13.09
4.3%
Showing 1–28 of 28.